Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) - Total Liabilities

Latest as of September 2024: TL120.48 Million TRY ≈ $2.70 Million USD

Based on the latest financial reports, Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has total liabilities worth TL120.48 Million TRY (≈ $2.70 Million USD) as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ONCSM cash flow conversion to assess how effectively this company generates cash.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. - Total Liabilities Trend (2020–2023)

This chart illustrates how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s total liabilities have evolved over time, based on quarterly financial data. See net assets of Oncosem Onkolojik Sistemler Sanayi ve Ti for net asset value and shareholders' equity analysis.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Competitors by Total Liabilities

The table below lists competitors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. ranked by their total liabilities.

Company	Country	Total Liabilities
Gabelli MultiMedia Mutual Fund NYSE:GGT	USA	$448.92K
Douglas Elliman Inc NYSE:DOUG	USA	$261.13 Million
Sebo Manufacturing Engineering & Construction Corp KQ:011560	Korea	₩136.26 Billion
BCB Bancorp Inc NASDAQ:BCBP	USA	$2.98 Billion
ANDHRA PAPER LIMITED NSE:ANDHRAPAP	India	Rs6.37 Billion
Annehem Fastigheter AB ST:ANNE-B	Sweden	Skr2.71 Billion
CF Bankshares Inc NASDAQ:CFBK	USA	$1.61 Billion

Liability Composition Analysis (2020–2023)

This chart breaks down Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.15	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.46	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)

The table below shows the annual total liabilities of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023.

Year	Total Liabilities	Change
2023-12-31	TL106.61 Million ≈ $2.39 Million	-15.06%
2022-12-31	TL125.50 Million ≈ $2.81 Million	+147.27%
2021-12-31	TL50.75 Million ≈ $1.14 Million	-9.55%
2020-12-31	TL56.11 Million ≈ $1.26 Million	--

About Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.

IS:ONCSM Turkey Medical Devices

Market Cap

$146.50 Million

TL6.54 Billion TRY

Market Cap Rank

#17742 Global

#245 in Turkey

Share Price

TL274.25

Change (1 day)

+0.83%

52-Week Range

TL76.85 - TL342.00

All Time High

TL342.00